The study was carried out to determine antimicrobial and haemolytic activities as well as to determine molecular weight breadth of Agelenopsis naevia venom components. Venom was extracted by micro-dissection. To measure the haemolytic activity, venom was incubated with 1% fresh human erythrocytes in 0.58 mg/ml, 2.54 mg/ml and 4.04 mg/ml for 1 hr, 2 hr, 4 hr and 6 hr while antimicrobial activity of venom was tested on Bacillus subtilis, Candida albicans, and Salmonella typhi. The venom protein molecular weights were determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and two-dimensional gel electrophoresis (2DE). The results show that haemolytic activity on human erythrocytes was dose-dependent and increased with time (42.40%–52.52%) with an effective concentration (EC50) of 2.07 mg/ml. The venom also showed significant (p < 0.05) activity against Bacillus subtilis (23.5 ± 0.50) compared to the positive and negative controls; however, there was no activity against Candida albicans or Salmonella typhi. SDS-PAGE revealed proteins/ peptides of molecular weights ranging between 6 kDa–97 kDa, while over 300 spots were detected on the 2D gel with molecular weight ranging from below 14 kDa–94 kDa and isoelectric point of 3–10 pI. This study concluded that A. naevia venom contains protein/peptides of various molecular weights with haemolytic activity on human erythrocytes and antimicrobial activity on Bacillus subtilis.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 17 • No. 8